SCHEMBL20189150

SCHEMBL20189150

Cc1cc(OC(F)(F)F)ccc1-c1cnnc(Cl)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN5A Q14524 2/20 0.49
CYP1A2 P05177 3/20 0.45
FFAR4 Q5NUL3 3/20 0.41
GPR3 P46089 4/20 0.40
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
PDE2A O00408 2/20 0.36
ABL1 P00519 2/20 0.36
CHRM5 P08912 1/20 0.36
CYP3A4 P08684 1/20 0.36
KCNH2 Q12809 1/20 0.36
CACNA1C Q13936 1/20 0.36
MCHR1 Q99705 1/20 0.36
ALOX5AP P20292 1/20 0.35
FEN1 P39748 1/20 0.35
HRH4 Q9H3N8 1/20 0.35
FFAR1 O14842 1/20 0.35
PDE7A Q13946 1/20 0.34
PDE11A Q9HCR9 1/20 0.34
PDE10A Q9Y233 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22712320 0.82 SCN5A (0.47) SCN5ACYP1A2FFAR4GPR3MAOA
SCHEMBL22738656 0.81 SCN5A (0.46) SCN5ACYP1A2FFAR4GPR3MAOA
SCHEMBL20188631 0.80 SCN5A (0.46) SCN5A
SCHEMBL20188635 0.79 SCN5A (0.49) SCN5ACYP1A2FFAR4GPR3MAOA
SCHEMBL22738657 0.75 SCN5A (0.42) SCN5ACYP1A2FFAR4GPR3MAOA
Acetic Acid SCHEMBL22712324 0.75 FFAR4 (0.42) SCN5ACYP1A2FFAR4ABL1CYP3A4
SCHEMBL21835698 0.74 CYP1A2 (0.54) SCN5ACYP1A2FFAR4GPR3MAOA
SCHEMBL22712325 0.74 SCN5A (0.41) SCN5ACYP1A2FFAR4MAOAMAOB
SCHEMBL28177887 0.73 SCN5A (0.51) SCN5ACYP1A2FFAR4GPR3CHRM5
Formic Acid SCHEMBL22712358 0.73 SCN5A (0.40) SCN5ACYP1A2FFAR4MAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11773099-B2 Compounds and their methods of use PRAXIS PRECISION MEDICINES, INC. (US) 2023-10-03 US disclosed
US-11773099-B2 Compounds and their methods of use PRAXIS PRECISION MEDICINES, INC. (US) 2023-10-03 US disclosed
US-11773099-B2 Compounds and their methods of use PRAXIS PRECISION MEDICINES, INC. (US) 2023-10-03 US disclosed
US-20210188839-A1 COMPOUNDS AND THEIR METHODS OF USE PRAXIS PRECISION MEDICINES, INC. 2021-06-24 US disclosed
US-20210188839-A1 COMPOUNDS AND THEIR METHODS OF USE PRAXIS PRECISION MEDICINES, INC. 2021-06-24 US disclosed
US-20200377506-A1 COMPOUNDS AND THEIR METHODS OF USE PRAXIS PRECISION MEDICINES, INC. 2020-12-03 US disclosed
US-20200377506-A1 COMPOUNDS AND THEIR METHODS OF USE PRAXIS PRECISION MEDICINES, INC. 2020-12-03 US disclosed
WO-2018098500-A1 COMPOUNDS AND THEIR METHODS OF USE PRAXIS PRECISION MEDICINES, INC. (US) 2018-05-31 WO disclosed
WO-2018098500-A1 COMPOUNDS AND THEIR METHODS OF USE PRAXIS PRECISION MEDICINES, INC. (US) 2018-05-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200377506-A1 COMPOUNDS AND THEIR METHODS OF USE SCN1A, SCN3A, SCN1B SCN5A 8/4885CYP1A2 1988/4885FFAR4 3542/4885
US-11773099-B2 Compounds and their methods of use SCN1A, SCN1B, SCN3A SCN5A 5/4885CYP1A2 1218/4885FFAR4 2946/4885
US-20210188839-A1 COMPOUNDS AND THEIR METHODS OF USE SCN1A, SCN3A, SCN1B SCN5A 8/4885CYP1A2 1988/4885FFAR4 3542/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.